Invesaro

Stocks Comparison

Archer-Daniels-Midland vs CVS HEALTH: revenue, profit, margins and growth compared

Archer-Daniels-Midland brought in $80.3B of revenue in fiscal 2025, CVS HEALTH $402.1B in fiscal 2025. Revenue changed by -6.2% at Archer-Daniels-Midland and +7.8% at CVS HEALTH on the year before, so CVS HEALTH grew faster. Archer-Daniels-Midland kept 1.3% of its revenue as net profit, CVS HEALTH 0.4%. Free cash flow was $4.2B at Archer-Daniels-Midland and $7.8B at CVS HEALTH.

Side by side, latest fiscal year

ADMCVS
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$80.3B$402.1B
Revenue growth-6.2%+7.8%
Net income$1.1B$1.8B
Net margin1.3%0.4%
Free cash flow$4.2B$7.8B
Free cash flow margin5.2%1.9%
Earnings per share (diluted)$2.23$1.39
Cash$1B$8.5B
Debt$7.6B$64.6B
Price to earnings36.464.1
Market value$39.1B$114B
Dividend yield2.51%2.98%
Rank by revenue in sector#6 of 93 · Consumer staples#1 of 93 · Consumer staples

Over the years

Revenue
ADM FY2018: $64.3BADM FY2019: $64.7BADM FY2020: $64.4BADM FY2021: $85.2BADM FY2022: $101.6BADM FY2023: $93.9BADM FY2024: $85.5BADM FY2025: $80.3BCVS FY2018: $194.6BCVS FY2019: $256.8BCVS FY2020: $268.7BCVS FY2021: $292.1BCVS FY2022: $322.5BCVS FY2023: $357.8BCVS FY2024: $372.8BCVS FY2025: $402.1BFY18FY19FY20FY21FY22FY23FY24FY25
ADM $80.3BCVS $402.1B
Net income
ADM FY2018: $1.8BADM FY2019: $1.4BADM FY2020: $1.8BADM FY2021: $2.7BADM FY2022: $4.3BADM FY2023: $3.5BADM FY2024: $1.8BADM FY2025: $1.1BCVS FY2018: -$594MCVS FY2019: $6.6BCVS FY2020: $7.2BCVS FY2021: $8BCVS FY2022: $4.3BCVS FY2023: $8.3BCVS FY2024: $4.6BCVS FY2025: $1.8BFY18FY19FY20FY21FY22FY23FY24FY25
ADM $1.1BCVS $1.8B
Net margin
ADM FY2018: 2.8%ADM FY2019: 2.1%ADM FY2020: 2.8%ADM FY2021: 3.2%ADM FY2022: 4.3%ADM FY2023: 3.7%ADM FY2024: 2.1%ADM FY2025: 1.3%CVS FY2018: -0.3%CVS FY2019: 2.6%CVS FY2020: 2.7%CVS FY2021: 2.7%CVS FY2022: 1.3%CVS FY2023: 2.3%CVS FY2024: 1.2%CVS FY2025: 0.4%FY18FY19FY20FY21FY22FY23FY24FY25
ADM 1.3%CVS 0.4%
Revenue growth
ADM FY2019: +0.5%ADM FY2020: -0.5%ADM FY2021: +32.5%ADM FY2022: +19.1%ADM FY2023: -7.5%ADM FY2024: -8.9%ADM FY2025: -6.2%CVS FY2019: +32.0%CVS FY2020: +4.6%CVS FY2021: +8.7%CVS FY2022: +10.4%CVS FY2023: +10.9%CVS FY2024: +4.2%CVS FY2025: +7.8%FY19FY20FY21FY22FY23FY24FY25
ADM -6.2%CVS +7.8%
Free cash flow
ADM FY2018: -$5.6BADM FY2019: -$6.3BADM FY2020: -$3.2BADM FY2021: $5.4BADM FY2022: $2.2BADM FY2023: $3BADM FY2024: $1.2BADM FY2025: $4.2BCVS FY2018: $6.8BCVS FY2019: $10.4BCVS FY2020: $13.4BCVS FY2021: $15.7BCVS FY2022: $13.5BCVS FY2023: $10.4BCVS FY2024: $6.3BCVS FY2025: $7.8BFY18FY19FY20FY21FY22FY23FY24FY25
ADM $4.2BCVS $7.8B

Fiscal years as each company reports them; the two may end in different months.

Questions about Archer-Daniels-Midland and CVS HEALTH

Which is bigger by revenue, Archer-Daniels-Midland or CVS HEALTH?

CVS HEALTH is bigger by revenue: $402.1B in fiscal 2025, against $80.3B for Archer-Daniels-Midland in fiscal 2025.

Which keeps more of its revenue as profit, Archer-Daniels-Midland or CVS HEALTH?

Archer-Daniels-Midland had a net margin of 1.3% in fiscal 2025; CVS HEALTH had 0.4% in fiscal 2025.

Which grew revenue faster, Archer-Daniels-Midland or CVS HEALTH?

In their latest fiscal years revenue changed by -6.2% at Archer-Daniels-Midland and +7.8% at CVS HEALTH.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies